Skip to main content
SpringerLink
Log in

State of Hypertension Control

  • Chapter
  • First Online:
Combination Therapy in Hypertension

Abstract

Almost one billion individuals worldwide are currently estimated to be affected by hypertension, or high blood pressure, with this figure predicted to rise to over 1.5 billion by 2025 [1]. Significantly, approximately one-half of this affected population is unaware of the condition [2], and, of those who are aware, more than half have not been treated [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365(9455):217–23.

    Google Scholar 

  • C hockalingam A. Impact of World Hypertension Day. Can J Cardiol 2007; 23(7):517–19.

    Google Scholar 

  • C hockalingam A. Editorial. News from the World Hypertension League (WHL). A division of the International Society of Hypertension, and in official relations with the World Health Organization. No. 107, June 2006.

    Google Scholar 

  • Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21(11):1983–92.

    Google Scholar 

  • Ram CV. Hypertension, possible vascular protection and lercanidipine. Expert Rev Cardiovasc Ther 2006; 4(6):783–8.

    Google Scholar 

  • E lliott WJ. Systemic hypertension. Curr Probl Cardiol 2007; 32(4):201–59.

    Google Scholar 

  • L awes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J H ypertens 2006; 24(3):423–30.

    Google Scholar 

  • H ypertension control. Report of a WHO Expert Committee. Technical Report Series, no. 862. Geneva: WHO, 1996.

    Google Scholar 

  • L awes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levels. J H ypertens 2006; 24(3):413–22.

    Google Scholar 

  • Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287(8):1003–10.

    Google Scholar 

  • C hockalingam A, Campbell NR, Fodor JG. Worldwide epidemic of hypertension. Can J Cardiol 2006; 22(7):553–5.

    Google Scholar 

  • T he Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. US Department of Health and Human Services. NIH Publication No. 04-5230. Bethesda, MD: National Institutes of Health, August 2004.

    Google Scholar 

  • N ilsson PM. Optimizing the pharmacologic treatment of hypertension: BP control and target organ protection. Am J Cardiovasc Drugs 2006; 6(5):287–95.

    Google Scholar 

  • Ho PM, Rumsfeld JS. Beyond inpatient and outpatient care: alternative model for hypertension management. BMC Public Health 2006; 6:257.

    Google Scholar 

  • World Health Organization. 2003 Summary: www.who.int/ cardiovascular_diseases/guidelines/hypertension/en. Last accessed May 2011.

  • H ossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world – a growing challenge. N Engl J Med 2007; 356(3):213–15.

    Google Scholar 

  • Journath G, Nilsson PM, Petersson U, Paradis BA, Theobald H, Erhardt L. Hypertensive smokers have a worse cardiovascular risk profile than non-smokers in spite of treatment – a national study in Sweden. Blood Press 2005; 14(3):144–50.

    Google Scholar 

  • Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360(9349):1903–13. 10 • combination therapy in hypertension.

    Google Scholar 

  • Khosla N, Black HR. Expanding the definition of hypertension to incorporate global cardiovascular risk. Curr Hypertens Rep 2006; 8(5):384–90.

    Google Scholar 

  • Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345(18):1291–7.

    Google Scholar 

  • A tilla K, Vasan RS. Prehypertension and risk of cardiovascular disease. Expert Rev Cardiovasc Ther 2006; 4(1):111–17.

    Google Scholar 

  • Chobanian AV, Bakris GL, Black HR, et al., National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289(19):2560–72. Epub 2003 May 14.

    Google Scholar 

  • Neutel JM. Combination therapy and the treatment of hypertension. Cardiology Special Edition 2003; 9(1 of 2):11–15.

    Google Scholar 

  • O ng KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension 2007; 49:69–75.

    Google Scholar 

  • O stchega Y, Sug Yoon S, Hughes J, Louis T, Division of Health and Nutrition Examination Surveys. Control – continued disparities in adults: United States, 2005–2006. NCHS Data Brief, no. 3. Hyattsville, MD: National Center for Health Statistics, January 2008. http://www.cdc.gov/nchs/data/databriefs/db03.pdf. Last accessed May 2011.

  • Neutel JM. The use of combination drug therapy in the treatment of hypertension. Prog Cardiovasc Nurs 2002; 17(2):81–8.

    Google Scholar 

  • F lack JM. Epidemiology and unmet needs in hypertension. J Manag Care Pharm 2007; 13(8 Suppl B):2–8.

    Google Scholar 

  • P rimatesta P, Poulter NR. Improvement in hypertension management in England: results from the Health Survey for England 2003. J Hypertens 2006; 24(6):1187–92.

    Google Scholar 

  • E fstratopoulos AD, Voyaki SM, Baltas AA, et al. Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study. Am J Hypertens 2006; 19(1):53–60.

    Google Scholar 

  • R edón J, Cea-Calvo L, Lozano JV, et al.; for the PRE V-ICT US study. Differences in blood pressure control and stroke mortality across Spain: the Prevención de Riesgo de Ictus (PRE V-ICT US) study. Hypertension 2007; 49(4):799–805.

    Google Scholar 

  • Cífková R. Arterial hypertension as a public health issue in the Czech Republic. Blood Press Suppl 2005; 2:25–8.

    Google Scholar 

  • B arbakadze VY, Koblianidze LG, Kipshidze NN, Grim CE, Grim CM, Tavill F. The Republic of Georgia High Blood Pressure Control Program. Ethn Dis 2006; 16(2 Suppl 2):S2-61–5.

    Google Scholar 

  • Hajjar I, Kotchen JM, Kotchen TA. Hypertension: trends in prevalence, incidence, and control. Annu Rev Public Health 2006; 27:465–90.

    Google Scholar 

  • Joffres MR, Hamet P, MacLean DR, L’italien GJ, Fodor G. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 2001; 14(11 Pt 1):1099–105.

    Google Scholar 

  • McLean D, Kingsbury K, Costello JA, Cloutier L, Matheson S; Canadian Hypertension Education Program. 2007 Hypertension Education Program (CHEP) recommendations: management of hypertension by nurses. Can J Cardiovasc Nurs 2007; 17(2):10–16.

    Google Scholar 

  • Neutel JM. Introduction. Am J Hypertens 2001; 14:1S–2S.

    Google Scholar 

  • S amuelsson OG, Wilhelmsen LW, Svärdsudd KF, Pennert KM, Wedel H, Berglund GL. Mortality and morbidity in relation to systolic blood pressure in two populations State of hypertension control • 11 with different management of hypertension: the study of men born in 1913 and the multifactorial primary prevention trial. J Hypertens 1987; 5:57–66.

    Google Scholar 

  • Grimm RH Jr, Flack JM, Byington R, Bond G, Brugger S. A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MI DAS). Drugs 1990; 40(Suppl 2):38–43.

    Google Scholar 

  • M oan A, Os I, Hjermann I, Kjeldsen SE. Hypertension therapy and risk of coronary heart disease: how do antihypertensives affect metabolic factors? Cardiology 1995; 86(2):89–93.

    Google Scholar 

  • Gueyffier F, Boissel JP, Boutitie F, et al. Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The IN DANA (IN dividual Data AN alysis of Antihypertensive intervention trials) Project Collaborators. Stroke 1997; 28(12):2557–62.

    Google Scholar 

  • Havlik RJ, LaCroix AZ, Kleinman JC, Ingram DD, Harris T, Cornoni-Huntley J. Antihypertensive drug therapy and survival by treatment status in a national survey. Hypertension 1989; 13(Suppl):I28–32.

    Google Scholar 

  • M acMahon SW, Cutler JA, Furberg CD, Payne GH. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis 1986; 29(3 Suppl 1):99–118.

    Google Scholar 

  • Neutel JM. Hypertension and its management: a problem in need of new treatment strategies. J Renin Angiotensin Aldosterone Syst 2000; 1(Suppl 2):10–13.

    Google Scholar 

  • Weber MA, Smith DH, Neutel JM, Graettinger WF. The therapeutic implications of left ventricular hypertrophy in the hypertensive patient. Am J Ther 1995; 2(12):972–7.

    Google Scholar 

  • N eutel JM, Smith DH, Graettinger WF, Winer RL, Weber MA. Heredity and hypertension: impact on metabolic characteristics. Am Heart J 1992; 124:435–40.

    Google Scholar 

  • Tatti P, Pahor M, Byington RP, et al. Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trial (FACET) in patients with hypertension and NI DDM. Diabetes Care 1998; 21:597–603.

    Google Scholar 

  • F urberg CD, Psaty BM, Pahor M, Alderman MH. Clinical implications of recent findings from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) and other studies of hypertension. Ann Intern Med 2001; 135:1074–8.

    Google Scholar 

  • Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827–38.

    Google Scholar 

  • R uzicka M, Leenen FH. Moving beyond guidelines: are report cards the answer to high rates of uncontrolled hypertension? Curr Hypertens Rep 2006; 8(4):324–9.

    Google Scholar 

  • Julius S, Cohn JN, Neutel J, et al. Antihypertensive utility of perindopril in a large, general practice-based clinical trial. J Clin Hypertens 2004; 6(1):10–17.

    Google Scholar 

  • Unger T, McInnes GT, Neutel JM, Böhm M. The role of olmesartan medoxomil in the management of hypertension. Drugs 2004; 64(24):2731–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internal Medicine, Orange County Research Center, Tustin, CA, USA

    Joel Neutel

Authors
  1. Joel Neutel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joel Neutel .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Healthcare

About this chapter

Cite this chapter

Neutel, J. (2011). State of Hypertension Control. In: Combination Therapy in Hypertension. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-908517-28-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-908517-28-9_1

  • Published:

  • Publisher Name: Springer Healthcare, Tarporley

  • Print ISBN: 978-1-908517-25-8

  • Online ISBN: 978-1-908517-28-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation